These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 24395048)

  • 21. Hypertriglyceridemia and cardiovascular risk reduction.
    Jacobson TA; Miller M; Schaefer EJ
    Clin Ther; 2007 May; 29(5):763-777. PubMed ID: 17697898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 2018 Guidelines for the management of dyslipidemia.
    Rhee EJ; Kim HC; Kim JH; Lee EY; Kim BJ; Kim EM; Song Y; Lim JH; Kim HJ; Choi S; Moon MK; Na JO; Park KY; Oh MS; Han SY; Noh J; Yi KH; Lee SH; Hong SC; Jeong IK
    Korean J Intern Med; 2019 Jul; 34(4):723-771. PubMed ID: 31272142
    [No Abstract]   [Full Text] [Related]  

  • 23. Treating hypertriglyceridemia.
    Holub BJ
    CMAJ; 2007 Sep; 177(6):604; author reply 604-5. PubMed ID: 17846446
    [No Abstract]   [Full Text] [Related]  

  • 24. Hypertriglyceridemia and the fibrate trials.
    Faergeman O
    Curr Opin Lipidol; 2000 Dec; 11(6):609-14. PubMed ID: 11086334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of hypertriglyceridemia: plasma exchange].
    Koike M; Nitta K
    Nihon Rinsho; 2013 Sep; 71(9):1667-9. PubMed ID: 24205732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypertriglyceridemia and Cardiovascular Outcomes.
    Malhotra G; Sethi A; Arora R
    Am J Ther; 2016; 23(3):e862-70. PubMed ID: 25415545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Triglycerides and cardiovascular risk.
    Jones A
    Heart; 2013 Jan; 99(1):1-2. PubMed ID: 23161618
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment options for severe hypertriglyceridemia (SHTG): the role of apheresis.
    Ewald N; Kloer HU
    Clin Res Cardiol Suppl; 2012 Jun; 7(Suppl 1):31-5. PubMed ID: 22528130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Update: clinical lipidology].
    Parhofer KG
    MMW Fortschr Med; 2013 Jul; 155(13):49-52; quiz 53-4. PubMed ID: 23964509
    [No Abstract]   [Full Text] [Related]  

  • 30. Is hypertriglyceridemia atherogenic?
    Roubille F; Sultan A; Huet F; Leclercq F; Macia JC; Gervasoni R; Delseny D; Akodad M; Roubille C
    Presse Med; 2018 Sep; 47(9):757-763. PubMed ID: 30262206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Why, when and how should hypertriglyceridemia be treated in the high-risk cardiovascular patient?
    Watts GF; Karpe F
    Expert Rev Cardiovasc Ther; 2011 Aug; 9(8):987-97. PubMed ID: 21878044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recommendations for severe hypertriglyceridemia treatment, are there new strategies?
    Filippatos TD; Elisaf MS
    Curr Vasc Pharmacol; 2014; 12(4):598-616. PubMed ID: 23627980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Triglycerides and cardiovascular disease.
    Nordestgaard BG; Varbo A
    Lancet; 2014 Aug; 384(9943):626-635. PubMed ID: 25131982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of hypertriglyceridemia.
    Capell WH; Eckel RH
    Curr Diab Rep; 2006 Jun; 6(3):230-40. PubMed ID: 16898578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A New Beginning for Triglyceride-Lowering Therapies.
    Pradhan AD
    Circulation; 2019 Jul; 140(3):167-169. PubMed ID: 30836784
    [No Abstract]   [Full Text] [Related]  

  • 36. Triglycerides and residual risk.
    Vallejo-Vaz AJ; Corral P; Schreier L; Ray KK
    Curr Opin Endocrinol Diabetes Obes; 2020 Apr; 27(2):95-103. PubMed ID: 32073428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of low high-density lipoprotein cholesterol and hypertriglyceridaemia in patients treated with hypolipidaemic drugs.
    Laforest L; Souchet T; Moulin P; Ritleng C; Desamericq G; Le Jeunne P; Schwalm MS; Van Ganse E
    Arch Cardiovasc Dis; 2009 Jan; 102(1):43-50. PubMed ID: 19233108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determining triglyceride reductions needed for clinical impact in severe hypertriglyceridemia.
    Christian JB; Arondekar B; Buysman EK; Jacobson TA; Snipes RG; Horwitz RI
    Am J Med; 2014 Jan; 127(1):36-44.e1. PubMed ID: 24384100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Severe hypertriglyceridaemia. Treatment with plasmapheresis.
    Izquierdo-Ortiz MJ; Abaigar-Luquin P
    Nefrologia; 2012 May; 32(3):417-8. PubMed ID: 22592440
    [No Abstract]   [Full Text] [Related]  

  • 40. Control of the overall lipid profile.
    Blasco M; Ascaso JF;
    Clin Investig Arterioscler; 2019 Dec; 31 Suppl 2():34-41. PubMed ID: 31785850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.